Showing 1261-1270 of 23044 results for "".
CDC - TB & HIV: A Deadly Duo, Part 2
https://reachmd.com/programs/grand-rounds-nation/cdc-tb-hiv-a-deadly-duo-part-2/6391/The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB deathAPP Biosimilar Education Video Series Module 1
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/app-biosimilar-education-video-series-module-1/15966/This series is designed to give advanced practice providers a better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosiThe Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://reachmd.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiRethinking MacTel: Cell-based Insights for Vision Preservation
https://reachmd.com/programs/cme/Rethinking-MacTel-Cell-Based-Insights-for-Vision-Preservation/35524/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://practicalneurology.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.DECAF Trial: Does Eliminating Coffee Reduce Atrial Fibrillation Recurrence in Symptomatic Patients?
https://reachmd.com/clinical-practice/cardiology/decaf-trial-does-eliminating-coffee-reduce-atrial-fibrillation-recurrence-in-symptomatic-patients/48690/Does caffeine abstinence affect atrial fibrillation recurrence in patients with symptomatic AF? Tune in for a review of the DECAF trial results!DARE AF Trial: Dapagliflozin to Reduce AF Burden After Catheter Ablation in Patients Without Diabetes or Heart Failure
https://reachmd.com/clinical-practice/cardiology/dare-af-trial-dapagliflozin-to-reduce-af-burden-after-catheter-ablation-in-patients-without-diabetes-or-heart-failure/48682/Can dapagliflozin reduce AF burden in your patients without diabetes or heart failure after ablation? Our expert is breaking down the DARE-AF trial results!ADAPT AF-DES: Antithrombotic Strategies Beyond 12 Months for Patients With AF Treated With Drug-Eluting-Stents
https://reachmd.com/clinical-practice/cardiology/adapt-af-des-antithrombotic-strategies-beyond-12-months-for-patients-with-af-treated-with-drug-eluting-stents/48694/Will ADAPT AF-DES findings affect your practice? Tune in for antithrombotic management strategies for patients with drug-eluting stents in the setting of AF.OCEAN Trial at AHA 2025: Anticoagulation After AF Ablation in High-Risk Patients
https://reachmd.com/clinical-practice/cardiology/ocean-trial-at-aha-2025-anticoagulation-after-af-ablation-in-high-risk-patients/48695/Review outcomes from the OCEAN trial assessing continued anticoagulation in patients with stroke risk factors after successful AF catheter ablation.How COVID-19 Is Affecting Life Outside of the Office: A Dermatologist’s Experience
https://reachmd.com/programs/covid-19-frontlines/how-covid-19-is-affecting-life-outside-of-the-office-a-dermatologists-experience/11363/Community support and outlets are becoming increasingly important during the COVID-19 pandemic. Here are some you can take advantage of.